Irbesartan Tablets Recalled for Impurity in Active Ingredient
Lupin Pharmaceuticals is recalling Irbesartan tablets due to the detection of N-nitrosoirbesartan impurity in the active pharmaceutical ingredient. The recall affects 30-count and 90-count bottles distributed nationwide.
- Product
- IRBESARTAN — IRBESARTAN (IRBESARTAN)
- Category
- Drug
- Distribution
- Distributed nationwide